Stock Price Movement and Market Context
On 21 Nov 2025, Sarda Proteins’ stock touched an intraday low of Rs.59.95, representing a gap down of 4.93% at the opening bell. Despite an intraday high of Rs.65, the share price closed near its lowest point for the day. This new low contrasts sharply with the stock’s 52-week high of Rs.137.45, indicating a decline of more than 56% from its peak within the last year.
The stock’s trading pattern has been somewhat erratic, with one day of non-trading recorded in the last 20 sessions. While it outperformed its sector by 3.41% on the day of the new low, the overall trend remains subdued. The stock’s price currently sits below its 5-day, 20-day, 50-day, and 100-day moving averages, though it remains above the 200-day moving average, signalling a complex technical picture.
In comparison, the Sensex opened lower at 85,347.40 points, down 0.33%, and was trading at 85,420.15 points (-0.25%) during the same period. The benchmark index is close to its 52-week high of 85,801.70 points, trading above its 50-day and 200-day moving averages, which indicates a generally bullish market environment contrasting with Sarda Proteins’ performance.
Financial Performance and Key Metrics
Over the past year, Sarda Proteins’ stock has recorded a return of -39.73%, significantly lagging behind the Sensex’s 10.68% gain. The company’s financial health appears strained, with reported losses impacting key profitability ratios. The return on equity (ROE) is negative, reflecting the company’s inability to generate profits from shareholders’ equity.
The company’s earnings before interest and tax (EBIT) to interest ratio averages at a low 0.01, indicating challenges in servicing debt obligations. This weak coverage ratio raises concerns about the company’s financial stability and its capacity to meet interest payments comfortably.
Additionally, the company’s earnings before interest, tax, depreciation, and amortisation (EBITDA) have been negative, contributing to the perception of elevated risk associated with the stock. Profitability has contracted by approximately 5% over the past year, further underscoring the financial pressures faced by the company.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
Position for Explosive Growth →
Long-Term and Recent Performance Trends
Sarda Proteins has underperformed not only in the last year but also over longer periods. The stock’s returns have lagged behind the BSE500 index over the last three years, one year, and three months. This consistent underperformance highlights ongoing challenges in the company’s business model and market positioning.
The edible oil sector, in which Sarda Proteins operates, has seen mixed results, with some companies managing to maintain stable growth while others face headwinds. Sarda Proteins’ inability to declare financial results for the past six months adds to the uncertainty surrounding its current standing.
Despite these difficulties, the company reported a notable increase in net sales during the half-year period ending June 2025, with net sales reaching ₹109.55 million. This figure represents a substantial growth rate of 18,127.29%, suggesting some positive movement in revenue generation, albeit from a low base.
Sarda Proteins or something better? Our SwitchER feature analyzes this small-cap Edible Oil stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Technical Indicators and Trading Patterns
The stock’s position relative to its moving averages offers insight into recent trading dynamics. While it remains above the 200-day moving average, the price is below the shorter-term averages (5-day, 20-day, 50-day, and 100-day), indicating downward momentum in the near term. This technical setup often reflects investor caution and a lack of sustained buying interest.
The intraday volatility, with a gap down opening and a wide trading range between Rs.59.95 and Rs.65, suggests uncertainty among traders. The stock’s failure to maintain gains during the day points to persistent selling pressure.
Sector and Market Comparison
Within the edible oil sector, Sarda Proteins’ performance contrasts with broader market trends. The Sensex’s proximity to its 52-week high and its trading above key moving averages indicate a generally positive market environment. The sector itself has seen varied performances, but Sarda Proteins’ stock has notably lagged behind both sector peers and the benchmark index.
This divergence highlights company-specific factors influencing the stock’s decline, including financial results, debt servicing capacity, and market sentiment.
Summary of Key Concerns
The primary factors contributing to Sarda Proteins’ stock decline to a 52-week low include the absence of recent financial disclosures, negative profitability metrics, and weak debt servicing ratios. The negative EBITDA and losses reported over the past year have weighed heavily on investor confidence, reflected in the stock’s substantial price drop.
While the company’s net sales growth in the recent half-year period offers a glimpse of potential improvement, the overall financial and market indicators suggest a cautious outlook for the stock’s near-term trajectory.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
